STOCK TITAN

Point72 (PGEN) reports 6.74M shares, 1.9% stake as of Mar 31, 2026

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G/A

Rhea-AI Filing Summary

Point72 Asset Management and affiliated filers report shared beneficial ownership of 6,741,861 shares of Precigen, Inc. Common Stock, representing 1.9% of the class as of March 31, 2026. The amount reported includes 97,500 shares issuable upon exercise of call options. The statement is filed on behalf of Point72 Asset Management, Point72 Capital Advisors, Inc., and Steven A. Cohen; all three report no direct sole ownership and disclose shared voting and dispositive power over the 6,741,861 shares.

Positive

  • None.

Negative

  • None.

Insights

Point72 reports a modest, passive stake with shared control and options exposure.

Point72 and its affiliates report 6,741,861 shares of Common Stock with shared voting and dispositive power as of March 31, 2026. The filing clarifies that the position includes 97,500 shares issuable upon exercise of call options.

The filing is a routine consolidated beneficial-ownership disclosure under Section 13; it notes shared control through management and adviser relationships. Cash-flow treatment and disposition plans are not stated in the excerpt; subsequent filings would show any trading activity.

This is an adviser-managed holding reported on behalf of funds and principal entities.

The statement identifies Point72 Asset Management as the investment manager with voting/dispositive power for an investment fund, Point72 Capital Advisors Inc. as general partner, and Steven A. Cohen as controller. The position is characterized as shared power rather than direct sole ownership.

Reported percentages and option overlays are precise: 1.9% of the class and 97,500 option-issuable shares. The filing emphasizes legal disclaimers about beneficial ownership determinations under Section 13.

Shared voting/dispositive power 6,741,861 shares as of March 31, 2026
Percent of class 1.9% percentage of Common Stock reported
Shares issuable on call options 97,500 shares included in the reported total
Shared Dispositive Power regulatory
"Shared Dispositive Power 6,741,861.00"
Call options financial
"Includes 97,500 shares of Common Stock issuable upon exercise of call options."
A call option is a contract that gives its buyer the right, but not the obligation, to buy a specific number of shares at a predetermined price within a set time. Think of it like a refundable reservation to purchase a stock later at today’s agreed price: investors use calls to profit from expected price rises with smaller upfront cost than buying the stock outright, or to hedge and manage exposure, while the most they can lose is the amount paid for the contract.
Beneficial ownership regulatory
"Amount beneficially owned: The information required by Item 4(a) is set forth in Row 9"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.





74017N105

(CUSIP Number)
03/31/2026

(Date of Event Which Requires Filing of this Statement)


Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)




schemaVersion:


SCHEDULE 13G




Comment for Type of Reporting Person: Includes 97,500 shares of Common Stock (as defined in Item 2(a)) issuable upon exercise of call options.


SCHEDULE 13G




Comment for Type of Reporting Person: Includes 97,500 shares of Common Stock issuable upon exercise of call options.


SCHEDULE 13G




Comment for Type of Reporting Person: Includes 97,500 shares of Common Stock issuable upon exercise of call options.


SCHEDULE 13G



Point72 Asset Management, L.P.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:05/15/2026
Point72 Capital Advisors, Inc.
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:05/15/2026
Steven A. Cohen
Signature:/s/ Jason M. Colombo
Name/Title:Jason M. Colombo, Authorized Person
Date:05/15/2026

FAQ

What stake does Point72 report in Precigen (PGEN)?

Point72 reports shared beneficial ownership of 6,741,861 shares, equal to 1.9% of Precigen's Common Stock, with figures stated as of March 31, 2026. The count includes 97,500 shares issuable upon exercise of call options.

Who filed the Schedule 13G/A for PGEN?

The filing was submitted on behalf of Point72 Asset Management, Point72 Capital Advisors, Inc., and Steven A. Cohen. Point72 Asset Management acts as investment manager and Point72 Capital Advisors Inc. is the general partner; Mr. Cohen controls both entities.

Does Point72 report sole voting or dispositive power over the reported shares?

No. The filing shows 0 shares of sole voting and sole dispositive power and reports shared voting and shared dispositive power over 6,741,861 shares as of March 31, 2026.